Market Size (2017)
$100.46M
Vertical: HealthcareBase Year: 201714 Sections
Market Size (2017)
$100.46M
Projected (2023)
$316.85M
CAGR (2015–2023)
21.1%
Key Players
10+
This report covers Healthcare Chatbots Market with forecasts from 2015 to 2023. 10 key companies are profiled.
The Healthcare Chatbots Market market is projected to grow at a CAGR of 21.1% from 2015 to 2023.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansA chatbot is a computer program or artificial intelligence that conducts a conversation via auditory or textual methods. Healthcare has become an alluring market for companies to develop chatbot applications for patients and clinicians.
Healthcare chatbots can be used in various applications such as monitoring health, assisting in medication, identify symptoms, and scheduling appointments. Today, we are witnessing the widespread use healthcare chatbots due to their ability to provide medical assistance to anyone at anytime and everywhere which overcomes the challenge of a lack of physicians in a large patient pool.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2017
Historical Period
2015 – 2016
Forecast Period
2018 – 2023
Primary Interviews
150+
Historical data (2015–2017) and forecast period (2017–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansGlobally there are many dominating players operating in this market. The Americas and the European region are a hub for major companies, generating maximum market share which has turned these regions into well-established markets. These companies have expanded their operating units in various other regions as well. Moreover, there are other small and medium scale players that generate revenue from local markets.
The above diagram displays the market ranking position of companies in the global healthcare chatbots market for2017. The global healthcare chatbots market is led by Your.MD (UK) followed by Buoy Health (US), Ada health GmbH (Germany), and Sensely (US).
Your.MD (UK) is one of the leading players in the healthcare chatbots market. The company focuses on offering technologically-advanced healthcare chatbot platforms. The company concentrates on developing advanced technological products and services in the market by increasing funding for healthcare chatbot platforms. For instance, in 2017, Your.MD (UK) raised USD 10 million for the development of technologically-advanced healthcare chatbots. This funding supports the firm to maintain its leading market position in the healthcare chatbots market.
Buoy Health (US) held the second largest share in the global healthcare chatbots market. The company is focused on maintaining its position by continuously raising funds for the development of healthcare-based chatbot platforms. Moreover, in 2017, the company raised around USD 6.7 million for research and development of artificial intelligence technology products and services which enhances the growth of Buoy Health in the healthcare chatbots market.
Ada health GmbH (Germany) held the third largest share in the market. The company develops and offers artificial intelligence-based chatbots in the market. The company offers ‘Ada - Your Health Guide” application in the healthcare chatbots market. This app serves in more than 130 countries.
Sensely Inc. (US) held the fourth largest share in the market. The company offers ‘Sensely” application in the healthcare chatbots market. This app maintains its position due to its wide services across the globe.
Bargaining Power of Suppliers
The suppliers in the global healthcare chatbots market are the developers of the healthcare chatbots software, and services. At present, there is huge availability of suppliers in the global healthcare chatbots market. However, this number is expected to grow during the projected period, contributing to a moderate-high bargaining power of the suppliers in the market.
Bargaining Power of Buyers
The bargaining power of buyers is moderate-low in the global healthcare chatbots market. The market consists of a limited number of buyers including various, hospitals, clinics, and others. Furthermore, the market is characterized by a moderate-high degree of brand identity. The buyers can exert moderate-low pressure on the market players for the delivery of high-quality healthcare chatbots software, platforms, and devices followed by after sales services.
Threat of New Entrants
The threat of new entrants is moderate in the global healthcare chatbots market. Any healthcare chatbots software, platform, and device developing company trying to enter the market is required to accept and abide by the mandatory regulatory standards. The healthcare chatbots market is characterized by a reasonable degree of brand loyalty. However, increasing use of software and technology in the healthcare industry is influencing many start-ups to take a keen interest in the field of healthcare IT.
Threat of Substitutes
The threat of substitutes in the global healthcare chatbots market is low. This can be attributed to the limited availability of products, and brand loyalty for major market players. The loyalty in the market is seen in terms of quality products and services delivered.
Rivalry
The intensity of rivalry in the healthcare chatbots market is moderate. A medium degree of product differentiation among existing players is increasing the intensity of rivalry in the market. Healthcare chatbots service companies are trying to develop less expensive platforms, so as to make healthcare chatbots set-ups affordable. The players in the market are more focused on developing advanced software and related platforms to overcome their rivals.
Market estimates by geography (2023)
InsightEurope leads with $129.36M by 2023, while North America is projected to grow fastest at a 21.8% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $3.22M | $5.75M | $9.83M | 15.0% | 3% |
| North America | $19.41M | $42.74M | $93.96M | 21.8% | 30% |
| Asia Pacific | $13.00M | $28.06M | $60.48M | 21.2% | 19% |
| Europe | $27.48M | $59.67M | $129.36M | 21.4% | 41% |
| South America | $5.29M | $11.10M | $23.22M | 20.3% | 7% |
| Total | $68.40M | $147.32M | $316.85M | 21.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$316.85M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Software | $263.00M | 21.4% | 83% |
| Services | $53.86M | 19.7% | 17% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Healthcare Chatbots Market covering market dynamics, competitive landscape, and strategic outlook.
The Healthcare Chatbots Market market is projected to reach $316.85M by 2023, growing at 21.1% CAGR. The Software segment holds the largest share.
A healthcare chatbot is a computer program used in healthcare applications such as the diagnosis of diseases and assistance in medications through conversations via auditory or textual methods. Healthcare has become a lucrative end-market for companies developing chatbot applications for patients and clinicians.
The market for healthcare chatbots is emerging due to improved internet connectivity and the growing adoption of smartphones and mobile platforms. Additionally, increasing chronic diseases and the lack of physicians, ensure the adoption and use of chatbots in healthcare applications.
However, concerns regarding data privacy and lack of awareness hamper the growth of the market.
According to the 2015 HIMSS Mobile Technology Survey, among 200 healthcare providers, around 90% were utilizing mobile devices to engage patients in their healthcare services. Additionally, the survey also stated that 93% of physicians believe that mHealth apps can improve patient’s health and 40% of physicians believe mHealth technologies can reduce the number of visits to doctors’ offices. Moreover, data published by Anthem Insurance Companies, Inc. stated that around 52% of smartphone users gather health information using mobile apps and 36% of doctors say apps are the most effective way to engage with patients.
This growing number of consumers adopting online healthcare services has broadened the demand for healthcare chatbots market. The rising adoption of mobile phone platforms and smart devices plays a key role in driving the market.
Developing economies create an opportunity for various markets as they have undeveloped research and development sector, due to which they are unable to address the upcoming health challenges. In spite of the high demand, regions such as Africa depend on imported medicines and other health technologies. Although there is a high requirement of treatment, poor economic conditions lead to the slow growth of the healthcare industry within the African region.
This undeveloped healthcare sector serves as an opportunity for healthcare chatbots providers as they can aim to strengthen their market presence in these developing regions.
Concerns regarding data privacy form a key challenge in the market for healthcare chatbots. Chatbots use Artificial Intelligence (AI) to process language in order to support interactions between humans and virtual assistants. As chatbots are actively being implemented in for services in hospitals and clinics for analysing patient data, security & privacy is one of the major challenges faced by the healthcare chatbots market. Patient data contains personal, private, or confidential health information and requires firm guidelines to prevent its misuse. Patient data is protected under various state and federal laws in many countries. Since chatbots find applications in personal patient care, it is mandatory for AI-based tools to comply with all regulatory rules and regulations implemented by the government and regulatory authorities.
Such concerns regarding data and stringent policies in order to protect data privacy is hampering the market growth.
Pricing is one of the most important factors for a product for sustenance in the market. The manufacturers should focus on the purchasing power of the consumer and manufacture cost-efficient products to achieve maximum profit and gain higher market share of the overall industry. Price of the healthcare chatbots varies in accordance to, intended use, and the brand. Furthermore, the market is driven by the demand for quality products, across the globe. Moreover, healthcare chatbots development require a high initial cost.
The investment in the healthcare chatbots market depends on various factors, including the pricing for healthcare chatbots services, government support, regional demand for the healthcare chatbot services and the cost of development.
The companies that are a well-established brands in the market have a variety of healthcare chatbot services and hold a large market share. The cost for healthcare chatbots set-ups is high, and a majority of users trust the more established brands. These companies can get a premium price for their products, which brings them high profits for their money invested. In most of the cases, innovation is the most important strategy. Similarly, investing in research & development to introduce new products with improved technology, can help increase their share in the global healthcare chatbots market. Furthermore, increasing prevalence of chronic diseases such as cancer, and diabetes along with the government support for research & development plays an important role in enhancing the global healthcare chatbots market. As there is a limited number of players in the market, many countries are encouraging companies to enter it. This can be seen in terms of increasing government incentives for the use various healthcare chatbot services and products. The healthcare chatbots manufacturers can grab these opportunities by investing in developing countries such as India, and China. These developing nations have a large number of patients, low labor cost, and a rapidly developing healthcare IT sector.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the Healthcare Chatbots Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Company Headquarter: Germany Founded: 2011 Company Working: Ada Health GmbH is an innovative health technology company that offers artificial intelligence technology chatbot platform for healthcare settings. The company provides Ada healthcare chatbot application is compatible with Android and iOS platforms and can provide assistance in French, Spanish, German, and Portuguese. This application used across ~130 countries.
Company Headquarter: London, UK Company Working: Babylon Health headquartered in London, UK. The company develop and offers its technological advanced healthcare chatbots in the market. The company offers artificial intelligence-based mobile application, that connects patients with doctors for better consultation. The application used by users for its personalized health assessments, treatment advice and face-to-face appointments.
Company Headquarter: Poland Founded: 2012 Company Working: Infermedica offers advanced artificial intelligence technology for preliminary medical diagnosis. This technology helps to improve the accuracy of diagnostic processes in healthcare settings. The company provides artificial intelligence health assessment tools to patients, clinics, and hospitals. Moreover, the company offers its advance technology platform to health insurance companies and healthcare systems. The company serves its products and services to companies such as Allianz Worldwide Partners, Dovera, Medicover, and HealthLoop.
Company Headquarter: London, UK Founded: 2012 Company Working: Your.MD develops and offers an application integrated with artificial intelligence-based personalized health assistance for individuals. This application is available on iOS, Android, and popular social messenger platforms such as, Kik, Telegram, Skype, Slack, and Facebook Messenger.
Company Headquarter: Netherlands Company Working: PACT Care BV develops software applicable in the health care industry. The company has developed an online personal health assistant application named Florence which helps the users to manage their health & wellness. Florence chatbot is an artificially intelligent and machine learning-based solution that is used by health organizations, professionals, and individuals. Florence chatbot is equipped with features such as, medication reminders, health tracker, and many others. This chatbots is available on messaging platforms such as Facebook’s Messenger, Kik, and Skype.
Coty is a fragrance-led global beauty company and, by its own description, one of the world's largest beauty groups, with FY2026 net revenues of USD 5.81bn split roughly two-thirds Prestige (licensed and owned luxury fragrance, prestige cosmetics and skincare — Burberry, Hugo Boss, Calvin Klein, Chloé, Marc Jacobs, Davidoff, Kylie Cosmetics, Gucci until mid-2027) and one-third Consumer Beauty (mass color cosmetics such as CoverGirl, Rimmel, Max Factor and Sally Hansen; mass fragrance; and Brazilian body care). Its core competitive asset is an end-to-end fragrance platform — licensing, innovation, ~81% in-house manufacturing and global prestige distribution — that has produced blockbuster franchises such as Burberry Goddess. After five years of deleveraging under Sue Nabi, Coty entered 2026 in a reset: revenue and margins are declining, the Gucci licence exits a year early, mass color and Brazil are under strategic review, and new interim leadership is executing a "Coty.Curated" focus-and-simplify framework with leverage of 3.4x. --- **Company's own description (paraphrased from FY2026 10-K, Item 1).** Coty describes itself as one of the world's largest beauty companies with an iconic brand portfolio across fragrance, color cosmetics, and skin and body care. It states that it is focused on leveraging its leadership position and capabilities in global fragrances to fuel expansion, strengthening its presence in a limited number of structurally profitable and growing categories, and prioritising growth channels such as e-commerce and Travel Retail. Under the Coty.Curated framework it emphasises fewer, bigger initiatives, marketing sufficiency, supply reliability, consumer advocacy, more productive innovation and portfolio choices, a return to market-share growth, and AI-powered, data-driven operations. It is also evaluating its central organisation, manufacturing and asset base to resize after the Gucci exit. **What the company does.** Coty designs, manufactures (≈81% in-house, ≈19% via third-party manufacturers in FY2026), markets and distributes beauty products. The essential oils in its fragrances are generally sourced from specialist fragrance houses; Coty owns the brand development, juice selection/briefing, bottle and packaging design, filling and assembly, marketing and commercial execution. Principal raw materials are essential oils, alcohols and specialty chemicals (10-K FY2026). **Business model and revenue model.** **Value-chain position.** Coty sits between ingredient suppliers (fragrance houses, alcohol and packaging suppliers) and retailers. Its economic moat lies in (i) licence portfolio scale in prestige fragrance, (ii) innovation and launch capability (brief-to-shelf), and (iii) owned manufacturing in the U.S., Europe and Brazil. It is structurally exposed to licensors (who own the trademarks) and to concentrated retailers (Sephora, Ulta, Douglas, Walmart, drug chains, travel-retail operators). **End markets.** Prestige fragrance (core), prestige cosmetics (Kylie Cosmetics, Marc Jacobs Beauty, Gucci Beauty until FY2027), prestige skincare (Lancaster, philosophy), mass color cosmetics, mass fragrance and mists, mass skin & body care (concentrated in Brazil). **Independent characterisation.** Coty is effectively two businesses with very different economics: a high-quality, licence-dependent prestige fragrance franchise generating ~20% adjusted EBITDA margins (Prestige FY2026 adjusted EBITDA margin 20.5% per Q4 FY2026 call), and a structurally challenged mass color cosmetics/Brazil business whose segment adjusted EBITDA margin collapsed to the low single digits in FY2026 (derived). The 2025–2026 strategic actions (Wella exit, Gucci monetisation, Consumer Beauty review) are converting Coty into a narrower fragrance pure-play with lower leverage but higher licence concentration.
12 interactive charts drawn from the Healthcare Chatbots Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Healthcare Chatbots Market South America Of South America
Global Healthcare Chatbots Market Germany, Spain, France, United Kingdom, Italy and Rest Of Western Europe Of Europe By Country
Global Healthcare Chatbots Market Australia, China, India, Japan, South Korea and Rest Of Asia Pacific By Country
Global Healthcare Chatbots Market United States and Canada Of North America By Country
Global Healthcare Chatbots Market Middle-East and Africa Of Middle East And Africa
Global Healthcare Chatbots Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)